Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Oxalomalic acid

From Bioblast
Revision as of 11:18, 2 June 2016 by Krumschnabel Gerhard (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision β†’ (diff)


high-resolution terminology - matching measurements at high-resolution


Oxalomalic acid

Description

Oxalomalic acid is an inhibitor of aconitase (and of cytoplasmic NADP-dependent isocitrate dehydrogenase). Aconitase mediates the isomerization of citrate to isocitrate as the first step in the TCA cycle. Oxalomalic acid has been used at 1 mM concentration and after 45 min of pre-incubation to inhibit aconitase in permeabilized rat Soleus muscle fibres, inhibiting the enzyme by 24% (Osiki 2016 FASEB J).


Reference: Osiki 2016 FASEB J






MitoPedia topics: Inhibitor